This article explores the strategic use of this election, highlighting its potential to optimize tax outcomes for both trusts and beneficiaries while cautioning against its pitfalls.

Troy Segal is an editor and writer. She has 20+ years of experience covering personal finance, wealth management, and business news. Suzanne is a content marketer, writer, and fact-checker. She holds ...

Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based ...

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.